Overview
Martin Frith practices in Tokyo, Japan. Mr. Frith is highly rated in 1 condition, according to our data. His top areas of expertise are Trichorhinophalangeal Syndrome Type 2, Myoclonic Epilepsy, Acrodysostosis, and Facioscapulohumeral Muscular Dystrophy (FSHD).
His clinical research consists of co-authoring 62 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Trichorhinophalangeal Syndrome Type 2
- Experienced
- AcrodysostosisMr. Frith isExperienced. Learn about Acrodysostosis.
- Cornelia De Lange SyndromeMr. Frith isExperienced. Learn about Cornelia De Lange Syndrome.
- Drug Induced DyskinesiaMr. Frith isExperienced. Learn about Drug Induced Dyskinesia.
- Facioscapulohumeral Muscular Dystrophy (FSHD)
- Myoclonic EpilepsyMr. Frith isExperienced. Learn about Myoclonic Epilepsy.
- Neuronal Intranuclear Inclusion Disease (NIID)